Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Oncogene|February 24, 2009
The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesisT R Hartman, E Nicolas, A Klein-Szanto, et al.American Journal of Respiratory and Critical Care Medicine|August 10, 2000
Pulmonary lymphangioleiomyomatosis in a manM C Aubry, J L Myers, J H Ryu, et al.Blood|April 15, 1994
Analysis of interphase cells for the Philadelphia translocation using painting probe made by inter-Alu-polymerase chain reaction from a radiation hybridD C Seong, M Y Song, E P Henske, et al.European Journal of Human Genetics : EJHG|January 1, 1995
Cosmid contigs spanning 9q34 including the candidate region for TSC1J Nahmias, N Hornigold, J Fitzgibbon, et al.American Journal of Human Genetics|August 1, 1996
Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesionsE P Henske, B W Scheithauer, M P Short, et al.The American Journal of Pathology|December 24, 1997
Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumorsE P Henske, L L Wessner, J Golden, et al.Cancer|November 25, 1998
Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complexT Al-Saleem, L L Wessner, B W Scheithauer, et al.Annals of Human Genetics|January 30, 1999
Comprehensive mutational analysis of the TSC1 gene: observations on frequency of mutation, associated features, and nonpenetranceJ Kwiatkowska, S Jozwiak, F Hall, et al.Cell Death & Disease|May 17, 2014
Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cellsY Sun, X Gu, E Zhang, et al.Nature Communications|November 12, 2021
A tissue-bioengineering strategy for modeling rare human kidney diseases in vivoJ O R Hernandez, X Wang, M Vazquez-Segoviano, et al.Pageof 5